Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Figure out How to Stay away from Normal Handshaking Missteps - 2Ten Awesome Authentic Realities That Will Leave You Interested
- 3France, Germany, Italy summon Iranian envoys over 'unbearable, inhumane' regime crackdown
- 4RFK Jr.'s diet guidelines emphasize red meat, full-fat dairy. How healthy are they?
- 56 Novice Cameras for 2024: Ideal for New Picture takers
- Figure out How to Consolidate Cutting edge innovations in Senior's SUVs
- Fiber is something most people could use more of. But experts advise caution with 'fibermaxxing'
- How many ships have been attacked in the Gulf since start of Iran war?
- China's 1st reusable rocket explodes in dramatic fireball during landing after reaching orbit on debut flight
- These HGTV stars made a pledge to keep their kids off smartphones. Here's how it's going.
- Grasping the Qualifications Among Separation and Dissolution
- Find the Excellence of Old style Expressive dance: Encountering the Effortlessness and Polish of Dance
- Nearly 16,000 New York City nurses prepare to strike as contract talks stall
- Vote in favor of your Number one method for commending a birthday
